The need for patient-tailored dosing of baclofen in future clinical trials ☆

Marie Costa 1, 2 Benjamin Rolland 3, 4 Patrizia Carrieri 1, 2, *
* Corresponding author
1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
2 ORS PACA - Observatoire régional de la santé Provence-Alpes-Côte d'Azur [Marseille]
3 Pôle MOPHA - SUAL - Service Universitaire d’Addictologie de Lyon [CH Le Vinatier, Bron]
4 CRNL - Centre de recherche en neurosciences de Lyon
Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

Cited literature [6 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02090030
Contributor : Christine Dupuis <>
Submitted on : Thursday, April 4, 2019 - 1:30:48 PM
Last modification on : Thursday, November 21, 2019 - 1:52:56 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

CNRS | UNIV-ST-ETIENNE | UNIV-LYON1 | IRD | UNIV-AMU | U1252 | UDL

Citation

Marie Costa, Benjamin Rolland, Patrizia Carrieri. The need for patient-tailored dosing of baclofen in future clinical trials ☆. European Neuropsychopharmacology, Elsevier, 2018, 28 (5), pp.656-657. ⟨10.1016/j.euroneuro.2018.03.001⟩. ⟨inserm-02090030⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

155

Contact

Informations

CCSD